PALISADE BIO, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-16.8M | $-14.4M | $-12.3M | $-14.3M | $-26.6M | $-10.3M | $-8.4M | $-4.9M |
| Depreciation & Amortization | — | — | — | $3.0K | $2.0K | $3.0K | $143.9K | $185.8K |
| Depreciation | $3.0K | $3.0K | $4.0K | $3.0K | — | $29.0K | $49.0K | $84.0K |
| Amortization | — | — | — | — | — | $63.0K | $95.0K | $102.0K |
| Stock-Based Compensation | $4.0M | $652.0K | $624.0K | $1.0M | $1.9M | $2.0M | $880.8K | $634.1K |
| Net Cash from Operating Activities | $-10.8M | $-12.2M | $-11.1M | $-13.4M | $-14.8M | $-4.8M | $-7.3M | $-7.7M |
| Investing Activities | ||||||||
| Capital Expenditures | — | $0 | $4.0K | $10.0K | $0 | $6.0K | — | $1.7K |
| Business Acquisitions | — | — | — | $0 | $3.3M | $0 | — | — |
| Net Cash from Investing Activities | — | $0 | $-4.0K | $-10.0K | $-54.0K | $-6.0K | — | $5.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $134.4M | $9.6M | $11.2M | $15.3M | $24.6M | $1.9M | $6.6M | $1.8M |
| Net Change in Cash | $123.6M | $-2.6M | $49.0K | $1.9M | $9.8M | $-2.9M | $-672.2K | $-887.8K |
| Free Cash Flow | — | $-12.2M | $-11.1M | $-13.4M | $-14.8M | $-4.8M | — | $-7.7M |